Advertisement

advertisement
OIAm2, LLC The Company




Members

Gilead's shares rise on report of experimental drug's promise in COVID-19

advertisement
Home Blogs > Business
Apr 17 '20 | By oiam2companyadmin | Views: 41 | Comments: 0

?m=02&d=20200417&t=2&i=1515493600&w=1200

Shares of Gilead Sciences Inc rose 10% in early trading on Friday after a report that patients with COVID-19 treated with the company's experimental drug, remdesivir, in a clinical trial showed rapid recovery in fever and respiratory symptoms.
businessNews?d=yIl2AUoC8zA businessNews?i=wgIjHuQ0Glw:X1CW_INBCpA:F businessNews?i=wgIjHuQ0Glw:X1CW_INBCpA:V

Source: https://www.reuters.com/article/us-gilead-sciences-stocks/gileads-shares-rise-on-report-of-experimental-drugs-promise-in-covid-19-idUSKBN21Z25V?feedType=RSS&feedName=businessNews

Share:
No comments
You need to sign in to comment
advertisement

Advertisement

advertisement
Google this
Tineye this
Bing this
Yandex this